|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003962,
umls-concept:C0019010,
umls-concept:C0022646,
umls-concept:C0026078,
umls-concept:C0028833,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0205191,
umls-concept:C0205373,
umls-concept:C0542341,
umls-concept:C1280500
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-3-23
|
|
pubmed:abstractText |
The adrenergic agonist midodrine improved circulatory and renal dysfunction when acutely administered in nonazotemic cirrhotic patients with ascites while its combination with octreotide has recently been proposed as an effective treatment of type 1 hepatorenal syndrome (HRS). However, the effects of octreotide on systemic hemodynamics and renal function in cirrhotic patients are controversial. This study evaluated the effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics, and function in nonazotemic cirrhotic patients with ascites.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
879-85
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15784036-Administration, Oral,
pubmed-meshheading:15784036-Adrenergic alpha-Agonists,
pubmed-meshheading:15784036-Adult,
pubmed-meshheading:15784036-Aged,
pubmed-meshheading:15784036-Aldosterone,
pubmed-meshheading:15784036-Blood Flow Velocity,
pubmed-meshheading:15784036-Drug Therapy, Combination,
pubmed-meshheading:15784036-Female,
pubmed-meshheading:15784036-Glomerular Filtration Rate,
pubmed-meshheading:15784036-Glucagon,
pubmed-meshheading:15784036-Hemodynamics,
pubmed-meshheading:15784036-Hepatorenal Syndrome,
pubmed-meshheading:15784036-Humans,
pubmed-meshheading:15784036-Injections, Subcutaneous,
pubmed-meshheading:15784036-Kidney,
pubmed-meshheading:15784036-Kidney Function Tests,
pubmed-meshheading:15784036-Male,
pubmed-meshheading:15784036-Middle Aged,
pubmed-meshheading:15784036-Midodrine,
pubmed-meshheading:15784036-Octreotide,
pubmed-meshheading:15784036-Regional Blood Flow,
pubmed-meshheading:15784036-Renin,
pubmed-meshheading:15784036-Vascular Resistance
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
|
|
pubmed:affiliation |
Department of Internal Medicine, Medical School, Ioannina, Greece.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
